Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.

Mona AschaXuan ZhouYoulan RaoOmar A MinaiAdriano R Tonelli

Published in: Cardiovascular therapeutics (2018)

Long-term anticoagulation with warfarin was not associated with any significant effect on survival in PAH or idiopathic PAH patients treated with SQ treprostinil.

Keyphrases

pulmonary arterial hypertension
atrial fibrillation
venous thromboembolism
pulmonary artery
pulmonary hypertension
direct oral anticoagulants
free survival
oral anticoagulants
polycyclic aromatic hydrocarbons
coronary artery